Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PNActive Not Recruiting
Sponsor: AstraZeneca
Neurofibromatosis Type 1
United States, Germany, Italy, Japan, Netherlands +2 more
Sponsor: Merck Sharp & Dohme LLC
Essential Thrombocythemia
United States, Argentina, Australia, Belgium, Canada +19 more
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Bulgaria, Chile, China +11 more
- A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a DayActive Not Recruiting
Sponsor: Novo Nordisk A/S
Short Stature Children Born Small for Gestational Age (SGA)
United States, Algeria, Austria, Canada, Denmark +18 more
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Brazil, Bulgaria, Canada +9 more
- Observational Study Protocol: LIVER-RRecruiting
Sponsor: AstraZeneca
Hepatobiliary Cancers
United States, Australia, Austria, Belgium, Brazil +17 more
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumor
United States, Belgium, France, Japan, Switzerland +1 more
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive Not Recruiting
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer
United States, Argentina, Australia, Austria, Belgium +33 more
- A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular DegenerationActive Not Recruiting
Sponsor: Astellas Pharma Inc
Geographic Atrophy · Age-Related Macular Degeneration
Japan
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Generalized Myasthenia Gravis
United States, Argentina, Australia, Belgium, Bulgaria +20 more
Sponsor: Gilead Sciences
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
United States, Argentina, Australia, Belgium, Brazil +18 more
Sponsor: Bristol-Myers Squibb
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +16 more
- A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)Active Not Recruiting
Sponsor: Arrowhead Pharmaceuticals
Homozygous Familial Hypercholesterolemia
United States, Australia, Austria, Belgium, Brazil +13 more
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationActive Not Recruiting
Sponsor: Novo Nordisk A/S
Heart Failure
United States, Argentina, Australia, Austria, Belgium +41 more
- Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.Active Not Recruiting
Sponsor: AstraZeneca
Eosinophilic Granulomatous Vasculitis
United States, Belgium, Canada, France, Germany +4 more
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis · Progressive Pulmonary Fibrosis
Japan
Sponsor: AstraZeneca
Clostridioides Difficile Infection
United States, Australia, Canada, Denmark, France +9 more
Sponsor: Genmab
Solid Tumors · Urothelial Carcinoma
United States, Japan, Spain
- A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Generalized Myasthenia Gravis
United States, Argentina, Australia, Brazil, China +13 more
Sponsor: Sumitomo Pharma America, Inc.
Solid Tumor
United States, Japan
- Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic SyndromeActive Not Recruiting
Sponsor: Shoichi Maruyama MD PhD
Glomerulonephritis, Membranous · Nephrotic Syndrome，Idiopathic
Japan
- A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)Not Yet Recruiting
Sponsor: Eli Lilly and Company
Pulmonary Disease, Chronic Obstructive
United States, Argentina, Austria, Canada, China +13 more
Sponsor: Novartis Pharmaceuticals
Chronic Myeloid Leukemia
United States, Argentina, Australia, Belgium, Brazil +13 more
Sponsor: Ionis Pharmaceuticals, Inc.
Angelman Syndrome
United States, Australia, Canada, Germany, Israel +7 more